Correction to: Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-P2 3-year results.
Publication Title
Clinical rheumatology
Document Type
Article
Publication Date
7-11-2022
Keywords
washington; swedish
Clinical Institute
Orthopedics & Sports Medicine
Specialty
Rheumatology
Specialty
Orthopedics
COinS